Investment Q&A

Q: Dear 5I Team:
I hold Visa for wonderful gains of 80%. Lately it's seems to be going sideways a for a bit. I've tried to follow your advice about not selling on momentum and holding for 5 years at least. Does this apply to Visa at them moment. Been fascinated to see how many of my Asian colleagues now using Visa in Thailand, Japan etc whereas 5 years ago, it was only cash when they made purchases. Thx for your advice. Lorraine

Q: Hello 5i Research team,
Would you say the acquisition of Biotoscana reduces the probability of GUD acquiring ENDO in the short term? Would GUD buy all ENDO, or exclusively the equivalent of the former Paladin? What premium or what price would you expect GUD to pay for ENDO if buying the whole company? What would be signs ENDO would be ripe to be saved?
Do you think the acquisition of Biotoscana will shut down Medison for a while? At least until after the next annual meeting, so that a second proxy fight would be avoided in the short term?
Based on the evolution of its stock price since its IPO, Biotoscana seemed not that successful as a stand alone company. What GUD can do to help turn things around / improve operations with such a small GUD team?
Thank you for your collaboration, Eric

Q: When IPL converted from a trust they provided the form for an election under 85(1), shareholders filed it out, sent to IPL to be signed by an official from IPL and IPL forwarded it to the CRA. I guess Boyd does not want to do this?

Q: I have been through the conversion from a trust to a corporation with inter pipeline and you are given a choice by the tax authorities to differ the taxes until you actually sell the shares. The're was no automatic capital gain at conversion.
Just a comment on Terry's assumption.

Q: Hi team

I seldom invest in healthcare stocks as they are a political football in the U.S. and often have binary outcomes with drug trials. It seems you either hit a home run or strike out. I saw a question earlier on BIIB. It is on my pharma/healthcare watch list. I am not sure why I even keep this list as I never buy anything off it. BIIB is now taking a 2nd look at trial data on an Alzheimer drug it dismissed as not promising six months ago. Now they view it as promising. It makes no sense to me. Did they hire a new scientist or sharpen the font on their computer screen? Others that I put on my list include AMRN and GH that to me also depend on binary outcomes on drug trials. My question is a general one. How does one develop a strategy for investing in health care stocks when it seems like they can jump or drop 30-50% overnight with the success or failure of a drug trial or the boss saying let’s take another look at this old data we dismissed earlier? Risk management seems very difficult in this sector.

Thanks again for the insight.
Dave

Q: is there a currency that Canadians could buy with Canadian dollars that is safer than our money . I am thinking that Canada's growing deficits, may not be good for the value of our dollar.

Q: I understand that there will be a capital gains tax generated in 2020 when Boyd converts to a corporation.
I currently have a profit of $57,000 on these shares which are held in a non registered account. I think that I should sell the shares now with a view of buying them back after 30 days as the tax rate could be higher next year
I believe the Liberals will agree with the Ndp to increase the capital gains inclusion rate next year if the Ndp agree not to block the Transmountain Pipe Line.
This will help appease the wexit provinces and generate additional tax revenue.
Should I sell the shares now or after the November 13th earnings report or sell half now and the other half after the report
Thank you for your excellent service and your recommendation on Boyd.







I

Q: Can you suggest solid companies that may have their prices depressed by tax loss selling and might be good buys this year?

Q: McDonald's Corp seems to have gone from a rock-solid blue-chip to a stock in free-fall in a very short time. Two senior analysts on BNN recently issued strong warnings against owning it. What do you think? What might be a good replacement for it for a 3-5 year hold?

Q: I sold my holdings in MX more than 30 days ago intending to buy in agail as I think the company has been unfairly beaten up. Considering tax loss selling, a spike seems remote unless they report amazing results on Oct 30. Do you think its too early to jump back in? Would it be prudent to to wait until maybe mid November. The charts are really unhelpful but it is above its 50 day moving average.

Q: HI
How safe is Arc's dividend if the price of oil stays flat? How safe is it if oil goes back into the 30's? Or, what scenario would lead Arc to cut its dividend?
thanks
Joe

Q: Any idea what is causing the move today? Thank-you.

Q: Peter; When are ALA’s earnings out and do you see anything Re today’s drop on volume? Thanks.Rod

Q: Is this a buy sell or hold I’ve made 20% if it’s a sell what would you replace with thanks

Q: hi
what should one be monitoring in order to get some info on whether or not the chip or appropriate tech sector is coming back to life?

Q: What comments do you have about FirstService and their results including weakness. Thank you.

Q: What’s your long term view of CRM please?
Thank you ,
Rick

Q: I am looking to invest in Canadian dividend paying stocks with growth potential. What do you recommend.

Q: This company has shown stronger results, more contracts and was slightly profitable for the last two quarters.However ,I am puzzled to see the weakness in the stock price over the last three months.What would be causing this and is it a good time to accumulate shares?
Thank you,
Jean

Q: Good morning 5i. My TFSA has re-trenched from a high of 108 k down to the low 90k's. My holdings were all good growth stocks but gone are TOY, SIS, NFL P.B.. I will jettison CAE this week. So I'm left with Go Easy, Boyd, and Kinaxis with a lot of cash. I will ad Bama, and Atd.B. Can you suggest 5 more dividend payers with some growth prospects for a 3 to 5 year hold. Many thanks .david